AbbVie, Inc.(NYSE : ABBV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Loading ABBV News...
Health Technology » Pharmaceuticals Major
|BMY||Bristol-Myers Squibb Company||2.46%||56.13||0.8%||$884.88m|
|JNJ||Johnson & Johnson||0.00%||119.66||0.6%||$880.91m|
|MRK||Merck & Co., Inc.||-0.28%||65.30||0.7%||$665.15m|
|LLY||Eli Lilly and Company||0.50%||80.76||1.0%||$316.52m|
|NVS||Novartis AG Sponsored ADR||0.02%||77.06||0.3%||$275.66m|
|AZN||AstraZeneca PLC Sponsored ADR||-0.19%||28.96||1.0%||$203.55m|
|GSK||GlaxoSmithKline plc Sponsored ADR||-1.20%||41.13||0.3%||$158.88m|
|NVO||Novo Nordisk A/S Sponsored ADR Class B||-0.16%||35.32||0.2%||$104.11m|
|SNY||Sanofi Sponsored ADR||-0.66%||42.48||0.2%||$68.42m|
|LCI||Lannett Company, Inc.||0.78%||22.73||33.3%||$26.82m|
|SCMP||Sucampo Pharmaceuticals, Inc. Class A||-2.58%||12.28||15.1%||$11.32m|
|EPIX||ESSA Pharma Inc||2.22%||2.30||0.0%||$0.01m|
|AKTX||Akari Therapeutics Plc Sponsored ADR||-1.47%||6.70||0.1%||$0.01m|
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.